Syndex Bio Inc. — Form D

Syndex Bio Inc. of SANTA MONICA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-14. The offering totals $15.5M, of which $15.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-03-14
• Form: D
• Accession: 0002060901-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $15.5M
• Amount sold: $15.5M
• Investors: 12
• Date of first sale: 2025-02-27
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-541005

Issuer

• Name: Syndex Bio Inc.
• CIK: 0002060901
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 2632 WILSHIRE BOULEVARD, SUITE 83, SANTA MONICA, CA, 90403
• Phone: 447876658351

Officers, directors & promoters (2)

More

• CIK 2060901 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search